Vitamin D receptor polymorphism Foki and cancer risk: A comprehensive meta-analysis

Carcinogenesis

Volumn 35, Issue 9, 2014, Pages 1913-1919

  Gnagnarella, Patrizia ^a   Pasquali, Elena ^a   Serrano, Davide ^a   Raimondi, Sara ^a   Disalvatore, Davide ^a   Gandini, Sara ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D RECEPTOR;

ARTICLE; BLADDER CANCER; BRAIN CANCER; CANCER RISK; CAUCASIAN; DNA POLYMORPHISM; ESOPHAGEAL ADENOCARCINOMA; ETHNICITY; FOKI GENE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENOTYPE; HARDY WEINBERG EQUILIBPHISM; HEAD AND NECK CANCER; HUMAN; LIVER CELL CARCINOMA; MALE BREAST CANCER; MALIGNANT NEOPLASTIC DISEASE; MOUTH SQUAMOUS CELL CARCINOMA; MYELOMA; NASOPHARYNX CARCINOMA; NONHODGKIN LYMPHOMA; OVARY CANCER; PANCREAS CANCER; SARCOMA; SKIN CANCER; SYSTEMATIC REVIEW; THYROID CARCINOMA;

CASE-CONTROL STUDIES; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, CALCITRIOL; RISK FACTORS;

EID: 84906824087     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu150     Document Type: Review

References (101)

1. Jemal,A. et al. (2011) Global cancer statistics. CA. Canc. J. Clin., 61, 69-90.
2. Vuolo,L. et al. (2012) Vitamin D and cancer. Front. Endocrinol. (Lausanne), 3, 58.
3. Luong,K.V. et al. (2010) The beneficial role of vitamin D and its analogs in cancer treatment and prevention. Crit. Rev. Oncol. Hematol., 73, 192-201.
4. Whitfield,G.K. et al. (2001) Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol. Cell. Endocrinol., 177, 145-159.
5. Uitterlinden,A.G. et al. (2004) Genetics and biology of vitamin D receptor polymorphisms. Gene, 338, 143-156.
6. Colin,E.M. et al. (2000) Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1, 25-dihydroxyvitamin D3. Clin. Endocrinol. (Oxf)., 52, 211-216.
7. Raimondi,S. et al. (2009) Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis, 30, 1170-1180.
8. Gandini,S. et al. (2009) Vitamin D and skin cancer: a meta-analysis. Eur. J. Cancer, 45, 634-641.
9. Stroup,D.F. et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA, 283, 2008-2012.
10. Tayeb,M.T. et al. (2004) Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia. Saudi Med. J., 25, 447-451.
11. Hutchinson,P.E. et al. (2000) Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin. Canc, Res., 6, 498-504.
12. Greenland,S. (1987) Quantitative methods in the review of epidemiologic literature. Epidemiol. Rev., 9, 1-30.
13. van Houwelingen,H.C. et al. (2002) Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat. Med., 21, 589-624.
14. Higgins,J.P. et al. (2002) Quantifying heterogeneity in a meta-analysis. Stat. Med., 21, 1539-1558.
15. von Elm,E. et al.; STROBE Initiative. (2008) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J. Clin. Epidemiol., 61, 344-349.
16. Macaskill,P. et al. (2001) A comparison of methods to detect publication bias in meta-analysis. Stat. Med., 20, 641-654.
17. Ferlay,J. et al. (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer, Lyon.
18. Li,C. et al. (2009) Vitamin D receptor gene polymorphisms and the risk of colorectal cancer in a Chinese population. Dig. Dis. Sci., 54, 634-639.
19. Anderson,L.N. et al. (2011) Vitamin D-related genetic variants, interactions with vitamin D exposure, and breast cancer risk among Caucasian women in Ontario. Canc. Epidemiol. Biomarkers Prev., 20, 1708-1717.
20. Grünhage,F. et al. (2008) Association of familial colorectal cancer with variants in the E-cadherin (CDH1) and cyclin D1 (CCND1) genes. Int. J. Colorectal Dis., 23, 147-154.
21. Cicek,M.S. et al. (2006) Vitamin D receptor genotypes/haplotypes and prostate cancer risk. Canc. Epidemiol. Biomarkers Prev., 15, 2549-2552.
22. Lesiak,A. et al. (2011) An enhanced risk of basal cell carcinoma is associated with particular polymorphisms in the VDR and MTHFR genes. Exp. Dermatol., 20, 800-804.
23. Gapska,P. et al. (2009) Vitamin D receptor variants and the malignant melanoma risk: a population-based study. Canc. Epidemiol., 33, 103-107.
24. Mittal,R.D. et al. (2007) Association of vitamin-D receptor (Fok-I) gene polymorphism with bladder cancer in an Indian population. BJU Int., 99, 933-937.
25. Toptaş,B. et al. (2013) The vitamin D receptor (VDR) gene polymorphisms in Turkish brain cancer patients. Biomed. Res. Int., 2013, 295791.
26. Yaylim-Eraltan,I. et al. (2007) Investigation of the VDR gene polymorphisms association with susceptibility to colorectal cancer. Cell Biochem. Funct., 25, 731-737.
27. Mohapatra,S. et al. (2013) Vitamin D and VDR gene polymorphism (FokI) in epithelial ovarian cancer in Indian population. J. Ovarian Res., 6, 37.
28. Correa-Cerro,L. et al. (1999) Vitamin D receptor polymorphisms as markers in prostate cancer. Hum. Genet., 105, 281-287. doi:10.1007/ s004399900119
29. Chokkalingam,A.P. et al. (2001) Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China. Canc. Res., 61, 4333-4336.
30. Oakley-Girvan,I. et al. (2004) Risk of early-onset prostate cancer in relation to germ line polymorphisms of the vitamin D receptor. Canc. Epidemiol. Biomarkers Prev., 13, 1325-1330.
31. Yang,Y. et al. (2004) Association of single nucleotide polymorphism of vitamin D receptor gene start codon and the susceptibility to prostate cancer in the Han nationality in Hubei area. Zhonghua Nan Ke Xue, 10, 411-414.
32. Hayes,V.M. et al. (2005) Genetic variants in the vitamin D receptor gene and prostate cancer risk. Canc. Epidemiol. Biomarkers Prev., 14, 997-999.
33. Mishra,D.K. et al. (2005) Association of vitamin D receptor gene polymorphism and risk of prostate cancer in India. Urol. Int., 74, 315-318.
34. Huang,S.P. et al. (2006) Association of vitamin D receptor FokI polymorphism with prostate cancer risk, clinicopathological features and recurrence of prostate specific antigen after radical prostatectomy. Int. J. Canc., 119, 1902-1907.
35. Holick,C.N. et al. (2007) Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer. Canc. Epidemiol. Biomarkers Prev., 16, 1990-1999.
36. Li,H. et al. (2007) A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med., 4, e103.
37. Mikhak,B. et al. (2007) Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk. Prostate, 67, 911-923.
38. Rukin,N.J. et al. (2007) Prostate cancer susceptibility is mediated by interactions between exposure to ultraviolet radiation and polymorphisms in the 5′ haplotype block of the vitamin D receptor gene. Canc. Lett., 247, 328-335.
39. Torkko,K.C. et al. (2008) VDR and SRD5A2 polymorphisms combine to increase risk for prostate cancer in both non-Hispanic White and Hispanic White men. Clin. Canc. Res., 14, 3223-3229.
40. Bai,Y. et al. (2009) Association of vitamin D receptor polymorphisms with the risk of prostate cancer in the Han population of Southern China. BMC Med. Genet., 10, 125.
41. Holt,S.K. et al. (2009) Vitamin D pathway gene variants and prostate cancer risk. Canc. Epidemiol. Biomarkers Prev., 18, 1929-1933.
42. Rowland,G.W. et al. (2013) Protective effects of low calcium intake and low calcium absorption vitamin D receptor genotype in the California Collaborative Prostate Cancer Study. Canc. Epidemiol. Biomarkers Prev., 22, 16-24.
43. Curran,J.E. et al. (1999) Association of a vitamin D receptor polymorphism with sporadic breast cancer development. Int. J. Canc., 83, 723-726.
44. Guy,M. et al. (2003) Approaches to evaluating the association of vitamin D receptor gene polymorphisms with breast cancer risk. Recent Results Canc. Res., 164, 43-54.
45. John,E.M. et al. (2007) Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population. Am. J. Epidemiol., 166, 1409-1419.
46. Abbas,S. et al. (2008) Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk. Breast Canc. Res., 10, R31.
47. Barroso,E. et al. (2008) Genetic analysis of the vitamin D receptor gene in two epithelial cancers: melanoma and breast cancer case-control studies. BMC Canc., 8, 385.
48. Gapska,P. et al. (2009) Vitamin D receptor variants and breast cancer risk in the Polish population. Breast Canc. Res. Treat., 115, 629-633.
49. Sinotte,M. et al. (2008) Vitamin D receptor polymorphisms (FokI, BsmI) and breast cancer risk: association replication in two case-control studies within French Canadian population. Endocr. Relat. Canc., 15, 975-983.
50. McKay,J.D. et al. (2009) Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Canc. Epidemiol. Biomarkers Prev., 18, 297-305.
51. Engel,L.S. et al. (2012) Vitamin D receptor gene haplotypes and polymorphisms and risk of breast cancer: a nested case-control study. Canc. Epidemiol. Biomarkers Prev., 21, 1856-1867.
52. Rollison,D.E. et al. (2012) Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U.S. Breast Canc. Res. Treat., 132, 683-691.
53. Fuhrman,B.J. et al. (2013) Sunlight, polymorphisms of vitamin D-related genes and risk of breast cancer. Anticancer Res., 33, 543-551.
54. Mishra,D.K. et al. (2013) Vitamin D receptor gene polymorphisms and prognosis of breast cancer among African-American and Hispanic women. PLoS One, 8, e57967.
55. Shahbazi,S. et al. (2013) BsmI but not FokI polymorphism of VDR gene is contributed in breast cancer. Med. Oncol., 30, 393.
56. Wong,H.L. et al. (2003) Vitamin D receptor start codon polymorphism and colorectal cancer risk: effect modification by dietary calcium and fat in Singapore Chinese. Carcinogenesis, 24, 1091-1095.
57. Murtaugh,M.A. et al. (2006) Vitamin D receptor gene polymorphisms, dietary promotion of insulin resistance, and colon and rectal cancer. Nutr. Canc., 55, 35-43.
58. Park,K. et al. (2006) Start codon polymorphisms in the vitamin D receptor and colorectal cancer risk. Canc. Lett., 237, 199-206.
59. Flügge,J. et al. (2007) Vitamin D receptor haplotypes protect against development of colorectal cancer. Eur. J. Clin. Pharmacol., 63, 997-1005.
60. Ochs-Balcom,H.M. et al. (2008) Association of vitamin D receptor gene variants, adiposity and colon cancer. Carcinogenesis, 29, 1788-1793.
61. Theodoratou,E. et al. (2008) Modification of the inverse association between dietary vitamin D intake and colorectal cancer risk by a FokI variant supports a chemoprotective action of vitamin D intake mediated through VDR binding. Int. J. Canc., 123, 2170-2179.
62. Wang,G. et al. (2008) [Polymorphism of vitamin D receptor Fok I and colorectal cancer risk in Chinese]. Zhong Nan Da Xue Xue Bao. Yi Xue Ban, 33, 399-403.
63. Jenab,M. et al. (2009) Vitamin D receptor and calcium sensing receptor polymorphisms and the risk of colorectal cancer in European populations. Canc. Epidemiol. Biomarkers Prev., 18, 2485-2491.
64. Slattery,M.L. et al. (2009) Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways. Mutat. Res., 660, 12-21.
65. Mahmoudi,T. et al. (2011) Start codon FokI and intron 8 BsmI variants in the vitamin D receptor gene and susceptibility to colorectal cancer. Mol. Biol. Rep., 38, 4765-4770.
66. Bentley,R.W. et al. (2012) Vitamin D receptor polymorphisms in colorectal cancer in New Zealand: an association study. N. Z. Med. J., 125, 47-51.
67. Rasool,S. et al. (2013) Association of a VDR gene polymorphism with risk of colorectal cancer in Kashmir. Asian Pac. J. Canc. Prev., 14, 5833-5837.
68. Sarkissyan,M. et al. (2014) Vitamin D receptor FokI gene polymorphisms may be associated with colorectal cancer among African American and Hispanic participants. Cancer, 120, 1387-1393.
69. Santonocito,C. et al. (2007) Association between cutaneous melanoma, Breslow thickness and vitamin D receptor BsmI polymorphism. Br. J. Dermatol., 156, 277-282.
70. Han,J. et al. (2007) Polymorphisms in the MTHFR and VDR genes and skin cancer risk. Carcinogenesis, 28, 390-397.
71. Li,C. et al. (2008) Haplotype and genotypes of the VDR gene and cutaneous melanoma risk in non-Hispanic whites in Texas: a case-control study. Int. J. Canc., 122, 2077-2084.
72. Randerson-Moor,J.A. et al. (2009) Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data. Eur. J. Canc., 45, 3271-3281.
73. Peña-Chilet,M. et al. (2013) rs12512631 on the group specific complement (vitamin D-binding protein GC) implicated in melanoma susceptibility. PLoS One, 8, e59607.
74. Clendenen,T.V. et al. (2008) Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer. Canc.. Lett., 260, 209-215.
75. Tworoger,S.S. et al. (2009) Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies. Canc. Res., 69, 1885-1891.
76. Lurie,G. et al. Ovarian Cancer Association Consortium (2011) Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium. Int. J. Canc., 128, 936-943.
77. Grant,D.J. et al. (2013) Vitamin D receptor (VDR) polymorphisms and risk of ovarian cancer in Caucasian and African American women. Gynecol. Oncol., 129, 173-178.
78. Mostowska,A. et al. (2013) Vitamin D receptor gene BsmI and FokI polymorphisms in relation to ovarian cancer risk in the Polish population. Genet. Test. Mol. Biomarkers, 17, 183-187.
79. Karami,S. et al. (2008) Vitamin D receptor polymorphisms and renal cancer risk in Central and Eastern Europe. J. Toxicol. Environ. Health. A, 71, 367-372.
80. Arjumand,W. et al. (2012) Vitamin D receptor FokI and BsmI gene polymorphism and its association with grade and stage of renal cell carcinoma in North Indian population. Tumour Biol., 33, 23-31.
81. Southard,E.B. et al. (2012) Lead, calcium uptake, and related genetic variants in association with renal cell carcinoma risk in a cohort of male Finnish smokers. Canc. Epidemiol. Biomarkers Prev., 21, 191-201.
82. Anic,G.M. et al. (2012) An exploratory analysis of common genetic variants in the vitamin D pathway including genome-wide associated variants in relation to glioma risk and outcome. Canc.Causes Contr., 23, 1443-1449.
83. Ruza,E. et al. (2003) Analysis of polymorphisms of the vitamin D receptor, estrogen receptor, and collagen Ialpha1 genes and their relationship with height in children with bone cancer. J. Pediatr. Hematol. Oncol., 25, 780-786.
84. Penna-Martinez,M. et al. (2009) Vitamin D receptor polymorphisms in differentiated thyroid carcinoma. Thyroid, 19, 623-628.
85. Chang,C.K. et al. FINBAR study group. (2012) Vitamin d receptor gene variants and esophageal adenocarcinoma risk: a population-based case- control study. J. Gastrointest. Canc., 43, 512-517.
86. Gu,H. et al. (2014) Vitamin D receptor gene polymorphisms and esophageal cancer risk in a Chinese population: a negative study. Med. Oncol., 31, 827.
87. Falleti,E. et al. (2010) Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis. World J. Gastroenterol., 16, 3016-3024.
88. Liu,Z. et al. (2005) Polymorphisms of vitamin D receptor gene protect against the risk of head and neck cancer. Pharmacogenetics Genom., 15, 159-165.
89. Kizildag,S. et al. (2011) Vitamin D receptor gene polymorphisms and male breast cancer risk in Turkish population. J. BUON., 16, 640-645.
90. Shafia,S. et al. (2013) Role of vitamin D receptor (VDR) polymorphisms in susceptibility to multiple myeloma in ethnic Kashmiri population. Blood Cells. Mol. Dis., 51, 56-60.
91. Purdue,M.P. et al. (2007) Vitamin D receptor gene polymorphisms and risk of non-Hodgkin's lymphoma. Haematologica, 92, 1145-1146.
92. Huang,X. et al. (2011) No association between Vitamin D receptor gene polymorphisms and nasopharyngeal carcinoma in a Chinese Han population. Biosci. Trends, 5, 99-103.
93. Zeljic,K. et al. (2012) Vitamin D receptor, CYP27B1 and CYP24A1 genes polymorphisms association with oral cancer risk and survival. J. Oral Pathol. Med., 41, 779-787.
94. Li,L. et al. (2013) Association of vitamin D receptor gene polymorphisms with pancreatic cancer: A pilot study in a North China Population. Oncol. Lett., 5, 1731-1735.
95. The World Health Organization. (2014). Ultraviolet Radiation and the INTERSUN Programme. World Health Organization, Geneva, Switzerland.
96. Xu,H. et al. (2013) The VDR gene FokI polymorphism and ovarian cancer risk. Tumour Biol., 34, 3309-3316.
97. Xu,Y. et al. (2014) Systematic review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Tumour Biol., 35, 4153-4169.
98. Zhao,X.Z. et al. (2014) Polymorphisms in the vitamin D receptor (VDR) genes and skin cancer risk in European population: a meta-analysis. Arch. Dermatol. Res., 306, 545-553.
99. John,E.M. et al. (2005) Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer. Canc. Res., 65, 5470-5479.
100. Mocellin,S. et al. (2008) Vitamin D receptor polymorphisms and the risk of cutaneous melanoma: a systematic review and meta-analysis. Cancer, 113, 2398-2407.
101. Denzer,N. et al. (2011) Vitamin D receptor (VDR) polymorphisms and skin cancer: A systematic review. Derm. Endocrinol., 3, 205-210.